KI-Beratung Beta
Vor Ort
Merkzettel Warenkorb
Produktbild: Rethinking Cognitive Enhancement

Rethinking Cognitive Enhancement

125,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

08.09.2016

Herausgeber

Ruud ter Meulen + weitere

Verlag

Oxford University Press

Seitenzahl

326

Maße (L/B/H)

25/17,5/2,2 cm

Gewicht

744 g

Sprache

Englisch

ISBN

978-0-19-872739-2

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

08.09.2016

Herausgeber

Verlag

Oxford University Press

Seitenzahl

326

Maße (L/B/H)

25/17,5/2,2 cm

Gewicht

744 g

Sprache

Englisch

ISBN

978-0-19-872739-2

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Rethinking Cognitive Enhancement


    • Preface


    • Editorial


    • List of Contributors


    • Part I: Introduction to the Volume


    • 1: Ruud ter Meulen, Ahmed Mohammed, and Wayne Hall: Should we get smarter by taking cognitive drugs? Towards a critical appraisal of arguments and evidence in the debate on cognitive enhancement


    • 2: Ruud ter Meulen: The ethical debate on human enhancement and cognitive enhancement by way of biotechnologies


    • Part II: Risk and benefits of the use of neuropharmacological drugs for cognitive enhancement


    • 3: Reinoud de Jongh: Overclocking the brain? The potential and limitations of Cognition-Enhancing Drugs


    • 4: Charles Massie, Eric Yamga, and Brendon Boot: Neuro-enhancement: a call for better evidence on safety and efficacy


    • 5: Andreas Heinz and Sabine Mÿller: Exaggerating benefits and downplaying risks in the debate on cognitive neuroenhancement


    • 6: Ahmed Mohammed: The Effects of Modafinil on Creativity: Results from a Randomized Controlled Trial


    • 7: Ahmed Mohammed: Does modafinil improve cognitive functioning in healthy individuals?


    • 8: Priyanka P. Shah-Basak and Roy H. Hamilton: Cognitive enhancement using noninvasive brain stimulation: weighing opportunity, feasibility, and risk


    • 9: Mark Attiah: The use of brain stimulation technology for cognitive enhancement and the potential for addiction


    • 10: Stephan Schleim and Boris B. Quednow: Debunking the ethical neuroenhancement debate


    • Part III: Ethical, philosophical, legal and policy issues of cognitive enhancement


    • 11: Ralph Hertwig and Thomas Hills: The evolutionary limits of enhancement


    • 12: Alex McKeown: Enhancement and therapy: is it possible to draw a line?


    • 13: Maartje Schermer: On the argument that enhancement is cheating


    • 14: Dan Stein: Psychiatric nosology and cognitive enhancement


    • 15: Heather Bradshaw-Martin: Will cognitive enhancement lead to more well-being? The case of people with disabilities


    • 16: Imogen Goold: The Legal Aspects of Cognitive Enhancement Legal regulations on cognitive enhancement practices


    • 17: Brad Partridge: Students and 'smart drugs': empirical research can shed light on enhancement enthusiasm


    • 18: Stephanie Bell, Jayne Lucke and Wayne Hall: Lessons for enhancement form the history of cocaine and amphetamine use


    • 19: Wayne Hall and John Strang: Drug policy and the public good: evidence for effective interventions